Skip to main content

Table 1 Baseline demographic, clinical and laboratory characteristics of the study population

From: Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention

  Total population (n = 2247) Lower GA (≤ 14.4%, n = 1133) Higher GA (> 14.4%, n = 1114) P value
Age, years 60.1 ± 9.0 58.2 ± 9.2 62.0 ± 8.3 < 0.001
Gender, male, n (%) 1616 (71.9) 864 (76.3) 752 (67.5) < 0.001
BMI, kg/m2 26.1 ± 3.2 26.2 ± 3.2 26.0 ± 3.2 0.323
Heart rate, bpm 69.7 ± 10.2 68.9 ± 9.6 70.6 ± 10.6 < 0.001
SBP, mmHg 130.2 ± 16.5 128.9 ± 15.9 131.6 ± 16.9 < 0.001
DBP, mmHg 77.0 ± 9.8 77.3 ± 9.3 76.7 ± 10.2 0.162
Smoking history, n (%) 1280 (57.0) 714 (63.0) 566 (50.8) < 0.001
Drinking history, n (%) 526 (23.4) 300 (26.5) 226 (20.3) 0.001
Family history of CAD, n (%) 233 (10.4) 120 (10.6) 113 (10.1) 0.728
Medical history, n (%)
 T2DM 774 (34.4) 101 (4.5) 673 (30.0) < 0.001
 Hypertension 1397 (62.2) 671 (59.2) 726 (65.2) 0.004
 Hyperlipidemia 1932 (86.0) 979 (86.4) 953 (85.5) 0.557
 Anemia 33 (1.5) 8 (0.7) 25 (2.2) 0.002
 Previous MI 473 (21.1) 220 (19.4) 253 (22.7) 0.056
 Previous PCI 376 (16.7) 161 (14.2) 215 (19.3) 0.001
 Previous stroke 259 (11.5) 113 (10.0) 146 (13.1) 0.020
 Previous PAD 79 (3.5) 36 (3.2) 43 (3.9) 0.380
Clinical diagnosis, n (%)
 UA 1873 (83.4) 951 (83.9) 922 (82.8) 0.456
 NSTEMI 374 (16.6) 182 (16.1) 192 (17.2)  
Laboratory examinations
 TG, mmol/L 1.5 (1.1, 2.1) 1.5 (1.1, 2.1) 1.4 (1.0, 2.1) 0.440
 TC, mmol/L 4.1 ± 1.0 4.2 ± 1.0 4.1 ± 1.0 0.029
 LDL-C, mmol/L 2.5 ± 0.9 2.5 ± 0.9 2.5 ± 0.8 0.022
 HDL-C, mmol/L 1.0 ± 0.2 1.0 ± 0.2 1.0 ± 0.2 0.261
 hs-CRP, mg/L 1.3 (0.6, 3.3) 1.2 (0.5, 2.9) 1.3 (0.6, 3.8) 0.006
 Creatinine, μmol/L 75.8 ± 16.5 76.9 ± 16.7 74.7 ± 16.3 0.001
 eGFR, mL/(min × 1.73 m2) 93.6 ± 20.0 93.7 ± 19.5 93.5 ± 20.5 0.790
 Uric acid, μmol/L 344.1 ± 80.4 358.6 ± 79.5 329.5 ± 78.6 0.001
 FBG, mmol/L 6.1 ± 1.9 5.3 ± 0.9 6.9 ± 2.3  < 0.001
 HbA1c, % 6.3 ± 1.2 5.7 ± 0.5 6.9 ± 1.4 0.001
 LVEF, % 64.0 ± 6.7 63.9 ± 7.0 64.0 ± 6.5 0.625
  1. GA glycated albumin, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, CAD coronary artery disease, T2DM type 2 diabetes mellitus, MI myocardial infarction, PCI percutaneous coronary intervention, PAD peripheral artery disease, UA unstable angina, NSTEMI non-ST-segment elevation myocardial infarction, TG triglyceride, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, hs-CRP high-sensitivity C-reactive protein, eGFR estimated glomerular filtration rate, FBG fasting blood glucose, HbA1c glycosylated hemoglobin A1c, LVEF left ventricular ejection fraction